Skip to main content
. 2004 Oct 18;2004(4):CD003367. doi: 10.1002/14651858.CD003367.pub2

3.3. Analysis.

3.3

Comparison 3: Sensitivity analysis: anthracyclines vs not, using studies with clearly described allocation concealment, Outcome 3: Overall response (assessable patients)